- ASC30 oral once-daily tablet demonstrated a 6.3% meanbody weight reduction from baseline after 28-day treatment in multiple ascending dose (MAD) cohort 2 (weekly titrations of 2 mg,10 mg,20 mg,and 4
XIAMEN,China,Feb. 19,2025-- Milesight,a leader in IP-based video surveillance solutions,is proud to unveil the G2 Series at its 2025 New Product Launch Event,redefining standards in video surveillanc
MILPITAS,Calif.,Feb. 19,2025-- SEMIEXPO Heartland,SEMI\'s first Midwestern U.S. exposition to be held April 1-2 at the Indiana Convention Center in Indianapolis,will feature a conference program high
SYDNEY,Feb. 19,2025-- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"),a clinical-stage radiopharmaceutical company with a mission to develop next-generation products t
The report explores policy,market,and innovation trends shaping this rapidly expanding industry HONG KONG and COLUMBUS,Ohio,Feb. 19,2025-- Deloitte and CAS,a division of the American Chemical Society
NEW YORK,Feb. 19,2025-- Tribesigns,a globally renowned furniture manufacturer and retailerofferingcozy and efficient home and office solutions forevery home,is thrilled to announce the debut of its n
